Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML

Leukemia. 2019 Jun;33(6):1541. doi: 10.1038/s41375-019-0415-y.

Jessica Barth^{1

2

3}, Khalil Abou-El-Ardat^{1

2

3}, Denis Dalic¹, Nina Kurrle¹, Anna-Maria Maier¹, Sebastian Mohr¹, Judith Schütte⁴, Lothar Vassen⁴, Gabriele Greve^{3

5

6}, Johannes Schulz-Fincke^{3

5

7}, Martin Schmitt⁷, Milica Tosic⁸, Eric Metzger⁸, Gesine Bug^{1

2

3}, Cyrus Khandanpour⁴, Sebastian A Wagner^{1

2

3}, Michael Lübbert^{3

5

6}, Manfred Jung^{3

5

7}, Hubert Serve^{1

2

3}, Roland Schüle^{8

9}, Tobias Berg^{10

11

12}

¹ Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany.
² German Cancer Consortium (DKTK), Frankfurt, Germany.
³ German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ Department of Medicine A, University Hospital Muenster, Muenster, Germany.
⁵ German Cancer Consortium (DKTK), Freiburg, Germany.
⁶ Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg Medical Center, Freiburg, Germany.
⁷ Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.
⁸ Department of Urology and Center for Clinical Research, University of Freiburg Medical Center, Freiburg, Germany.
⁹ BIOSS Centre for Biological Signalling Studies, Albert-Ludwigs-University, 79104, Freiburg, Germany.
¹⁰ Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany. [email protected].
¹¹ German Cancer Consortium (DKTK), Frankfurt, Germany. [email protected].
¹² German Cancer Research Center (DKFZ), Heidelberg, Germany. [email protected].

Abstract

The original version of this Article contained an error in the Acknowledgements section.